Callaly wins global Hygienix Innovation Award by INDA

In early 2019, Callaly will expand its product range to sell tampons, pads and liners alongside Tampliners, all customisable and delivered monthly. The brand has also got its sights set on further product innovation in the future, having secured patent grants for a new design for an internal drug delivery.

Callaly is a great supporter of British industry, with all its products developed, manufactured and packed in the UK.  The fact that periods and period products are still a taboo topic, especially in the boardroom, hasn’t stopped the brand from pursuing their dream of bringing a new product to market while fighting for higher standards across the femcare industry. Half of the current investors said no when first approached, largely because periods and feminine hygiene were a low-interest and taboo area for investors. However this hasn’t fazed the brand, who aim to sell their two millionth product next year.

“Every startup with a disruptive product faces the challenge of convincing investors, suppliers and researchers to trust and support them on their journey. Being in the femcare industry, which is still subject to outdated taboos, makes this twice as tricky. But it has been worth it to get the right support behind us. We feel privileged to be able to work on new meaningful innovations that don’t just provide value, but also improve users’ health and offer more choice to people with periods,” said CEO and co-founder Thang Vo-Ta. (PC)

Fibre2Fashion News Desk – India